<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgments</title>
 <p>The authors would like to acknowledge Genzyme/Sanofi Oncology for research support and providing plerixafor, the investigational product for this trial. The authors are grateful to Wen Xie for expert technical assistance. The authors also gratefully acknowledge contributors to Leukemia Fighters. MG and GR were partially supported by LLS 6427-13, DP2 OD007399, R01 CA102031. Dr. Paul Christos was partially supported by the following grant: Clinical and Translational Science Center at Weill Cornell Medical College (UL1-TR000457-06).</p>
</ack>
